Characteristic | No cardiac arrest within 72 hours (n= 882) | Cardiac arrest within 72 hours (n= 43) | P valuea |
---|---|---|---|
Age (years) | Â | Â | Â |
   Median (IQR) | 62 (50 to 74) | 70 (59 to 78) | 0.018 |
Male gender | 542 (61.5) | 31 (72.1) | 0.198 |
Race | Â | Â | Â |
   Chinese | 586 (66.4) | 35 (81.4) |  |
   Malay | 130 (14.7) | 5 (11.6) | 0.134 |
   Indian | 118 (13.4) | 1 (2.3) |  |
   Others | 48 (5.4) | 2 (4.7) |  |
Diagnosis groupingb | Â | Â | Â |
   Cardiovascular | 359 (40.7) | 9 (20.9) |  |
   Respiratory | 137 (15.5) | 10 (23.3) |  |
   Neurological | 87 (9.9) | 4 (9.3) |  |
   Gastrointestinal | 46 (5.2) | 0 (0) |  |
   Renal | 25 (2.8) | 0 (0) |  |
   Endocrine | 58 (6.6) | 4 (9.3) | 0.275 |
   Infectious diseases | 59 (6.7) | 1 (2.3) |  |
   Vascular | 22 (2.5) | 3 (7.0) |  |
   Trauma | 31 (3.5) | 2 (4.7) |  |
   Cancer | 28 (3.2) | 9 (20.9) |  |
   Others | 30 (3.4) | 1 (2.3) |  |
Medical historyc | Â | Â | Â |
   Diabetes | 295 (33.4) | 5 (11.6) | 0.405 |
   Hypertension | 472 (53.5) | 18 (41.9) | 0.876 |
   Heart disease | 292 (33.1) | 12 (27.9) | 0.868 |
   Renal disease | 115 (13.0) | 6 (14.0) | 0.251 |
   Respiratory disease | 103 (11.7) | 7 (16.3) | 0.222 |
   Stroke | 63 (7.1) | 0 (0) | 1.000 |
   Cancer | 69 (7.8) | 2 (4.7) | 1.000 |
   Others | 523 (59.3) | 32 (74.4) | 0.204 |
Prior medical therapyd | Â | Â | Â |
   Beta-blockers | 227 (25.7) | 14 (32.6) | 0.726 |
   Calcium-channel blockers | 165 (18.7) | 11 (25.6) | 0.432 |
   Digoxin | 36 (4.1) | 2 (4.7) | 0.415 |
   Amiodarone | 12 (1.4) | 0 (0) | 1.000 |
   Other anti-arrythmics | 5 (1.4) | 0 (0) | 1.000 |